





































JEM © The Rockefeller University Press  $8.00
Vol. 203, No. 4,  April 17, 2006  919–932  www.jem.org/cgi/doi/10.1084/jem.20052237
919
By virtue of their abilities to persist, undergo 
substantial secondary expansion in response to 
reinfection, and rapidly elaborate antimicrobial 
eff   ector mechanisms, memory T cells pro-
vide enhanced resistance to infection with intra-
cellular pathogens (1). Thus, generation of 
memory T cell responses is an important goal 
of vaccination, and much attention has been 
  devoted to understanding the properties of 
memory CD8 T cells in experimental models. 
However, despite intense investigation, no sin-
gle property or phenotypic marker has been 
revealed that will unequivocally identify a 
memory CD8 T cell. Furthermore, although 
most human vaccines involve multiple booster 
immunizations to generate secondary or ter-
tiary memory populations (2), the vast majority 
of experimental studies to date have been per-
formed on primary memory CD8 T cell popu-
lations. Thus, it is unknown if primary and 
secondary memory CD8 T cell populations 
are endowed with similar characteristics and 
whether these two populations are able to pro-
vide the same degree of protective immunity.
In response to infection of a naive host, 
  pathogen-specifi  c CD8 T cells expand in num-
ber, diff  erentiate into eff  ector cells that migrate 
throughout the body, and contribute to patho-
gen clearance (3–5). This expansion phase, 
which generally lasts for 7–10 d after acute 
  infection, is followed by a programmed con-
traction phase in which  90–95% of eff  ector 
T cells are eliminated by apoptosis (6). The re-
maining antigen-specifi  c CD8 T cells form the 
initial primary memory pool, which can re-
main stable in number for the life of the host 
(7–10). Interestingly, recent studies reveal sub-
stantial changes in the phenotype and function 
of memory CD8 T cell populations with time 
after infection (11). Specifi  cally, early memory 
is composed predominantly of antigen-specifi  c 
CD8 T cells that display an eff  ector–memory 
phenotype. These cells are readily able to cir-
culate through the blood and enter periph-
eral tissues and spleen but are excluded from 
lymph nodes because they lack important adhe-
sion  (CD62L) or chemokine receptor (CCR7) 
molecules (12, 13). In contrast, the majority of late 
memory CD8 T cells display a so-called central–
memory phenotype and have regained surface 
expression of the molecules required to enter 
lymph nodes as well as the ability to produce 
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IL-2, in addition to IFN-γ, after antigen stimulation (14, 15). 
Although an early study was consistent with eff  ector–memory 
T cells (TEM) and central–memory T cells (TCM) having 
  diff  erent proliferative and protective functions (14), this has 
been recently questioned (16). In addition, recent studies 
from our laboratory suggest that the rate at which CD8 
T cells acquire memory characteristics is not fi  xed, but rather 
controlled by infl  ammatory signals received by T cells during 
the initial stages of priming (17, 18). Thus, primary memory 
CD8 T cells generated by diff  erent infections or vaccination 
regimens may progress at diff  erent rates in their acquisition of 
specifi  c memory characteristics.
In contrast, much less is known about the phenotype and 
function of secondary memory CD8 T cells. In general, 
boosting an immune host with higher doses of infection or 
heterologous antigen delivery vectors induces secondary 
  expansion in the numbers of primary memory CD8 T cells, 
resulting in increased numbers of secondary memory CD8 
T cells (2, 19). Whether these secondary memory CD8 
T cells remain stable in number or progress from TEM to TCM 
has not been determined. Importantly, analysis of secondary 
memory T cells generated by reinfection or secondary immu-
nization of a previously immune animal is complicated by the 
likelihood that naive precursors, either remaining unrecruited 
cells or newly generated precursors, will become   activated 
and undergo a normal primary response to generate new pri-
mary memory T cells (20). Thus, boosting previously immu-
nized mice may, in fact, engender mixtures of primary and 
secondary responses. To overcome this limitation, we 
(6, 20) and others (21, 22) have used adoptive transfer of rela-
tively small numbers of allelically marked primary memory 
CD8 T cells into naive hosts followed by infection to generate 
primary and secondary CD8 T cell responses in the same ani-
mal that can readily be distinguished. Using this approach, we 
previously documented that the contraction phase of sec-
ondary CD8 T cell responses is delayed compared with the 
primary response after both viral and bacterial infection 
(6, 20). Similar results were obtained using viral infection and 
a TCR-transgenic (tg) T cell adoptive transfer model (21). 
In the current study, we used similar approaches to compare 
the phenotype and function of primary and secondary mem-
ory populations after infection. Compared with primary 
memory populations, secondary memory CD8 T cell popula-
tions exhibit a substantial delay in reacquisition of CD62L 
  expression and the ability to produce IL-2, both important 
characteristics of TCM. Despite this, secondary memory CD8 
T cell populations were able to expand as well as primary 
memory CD8 T cell populations in response to antigen and, 
remarkably, were able to provide enhanced protective 
  immunity against pathogen challenge. Furthermore, the in-
ability of secondary memory CD8 T cells to traffi   c to the 
lymph nodes correlated with their ability to permit a new 
  naive T cell response to be initiated. Thus, secondary memory 
CD8 T cells have properties that are functionally distinct from 
primary memory CD8 T cells, and the number of encounters 
with antigen infl  uences memory CD8 T cell function.
RESULTS
Delayed CD62L expression by secondary memory cells
The primary CD8 T cell response to infection consists of ex-
pansion and diff  erentiation to eff  ector cells, followed by rapid 
contraction to stable numbers of memory cells. Importantly, 
recent evidence demonstrates that early primary memory 
CD8 T cells are CD62Llo (consistent with an eff  ector–mem-
ory phenotype), whereas at later time points, the population 
of primary memory CD8 T cells are primarily CD62Lhi (con-
sistent with a central–memory phenotype) (11). This pattern 
of diff  erentiation may be important in both immune func-
tion and vaccination, because, in at least some circumstances, 
TCM provide superior protection to TEM (14). To determine 
if secondary CD8 T cell responses exhibit the same pattern of 
diff  erentiation, we initially infected BALB/c mice (Thy1.2) 
with lymphocytic choriomeningitis virus (LCMV) to elicit 
primary memory CD8 T cells specifi   c for the dominant 
  nucleoprotein (NP)118 epitope (23). Approximately 2 × 104 
primary NP118-specifi  c memory CD8 T cells, obtained 129 d
after infection, were then transferred into naive Thy1.1 
BALB/c mice. This experimental design allowed us to track 
both primary and secondary CD8 T cell responses in the 
same host, thus minimizing a potential source of environ-
mental variability. The recipient mice were then infected 
with LCMV, and NP118-specifi  c primary (Thy1.2neg) and 
secondary (Thy1.2pos) CD8 T cell responses were identi-
fi  ed by NP118/Ld tetramer staining (Fig. 1 A). As previously 
noted (20), under these conditions both primary and second-
ary CD8 T cell responses exhibit vigorous expansion after 
LCMV infection (Fig. 1 B). As expected, the majority of 
primary NP118-specifi  c eff  ector CD8 T cells were CD62Llo 
at day 8 after LCMV infection, whereas the majority of pri-
mary memory CD8 T cells at day 72 were CD62Lhi (Fig. 
1 C), indicating a normal progression to TCM. Similarly, 
NP118-specifi  c secondary eff  ector CD8 T cells in the same 
mice were also CD62Llo at day 8 after infection. In sharp 
contrast to primary memory CD8 T cells, however, second-
ary memory CD8 T cells remained primarily CD62Llo at day 
72 (Fig. 1 C). Delayed acquisition of CD62L by secondary 
memory CD8 T cells was also observed with the same adop-
tive transfer protocol followed by challenge infection with 
a recombinant Listeria monocytogenes strain (LM-NPs [24]) 
expressing the NP118 epitope as a secreted fusion protein 
(Fig. 1 D), indicating that delayed acquisition of CD62L by 
secondary memory CD8 T cells also occurs after bacterial 
infection. Finally, we observed similar delayed acquisition of 
CD62L by secondary memory CD8 T cells specifi  c for the 
ova257 epitope in previously immunized B6 mice, compared 
with naive B6 mice, after challenge with L. monocytogenes 
expressing the ova257 epitope (LM-OVA [25, 26]) (Fig. 1 E),
indicating that this observation is not limited to BALB/c 
mice, the NP118-specifi  c CD8 T cell response, or adoptive 
transfer models. Thus, compared with primary memory 
CD8 T cells, secondary memory CD8 T cells do not rapidly 
reacquire expression of surface CD62L, one of the major 
characteristics of TCM.JEM VOL. 203, April 17, 2006  921
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Secondary memory cells eventually acquire 
TCM characteristics
To eliminate the potential that precursor frequency (27) or 
changes in TCR utilization could infl  uence the results, and 
to develop a model where we could purify memory T cells 
without ligating the TCR, we next analyzed CD62L expres-
sion in primary and secondary memory Thy1.1 OT-I TCR-
tg CD8 T cells (specifi  c for ova257 [28]). CD8-enriched 
naive OT-I T cells (2 × 104) were transferred into naive B6 
(Thy1.2) mice, and primary OT-I T cell responses were 
generated by infection with LM-OVA. 5 × 104 Thy1.1-pu-
rifi  ed primary memory OT-I T cells (obtained >100 d after 
stimulation) or similarly purifi  ed naive OT-I T cells were 
then transferred into separate groups of naive B6 mice fol-
lowed by infection with LM-OVA 1 d later to stimulate sec-
ondary and primary OT-I T cell responses, respectively. 
Both populations of OT-I T cells underwent substantial ex-
pansion after infection and generated memory populations 
(Fig. 2 A). As seen with nontransgenic T cells, both popula-
tions of OT-I T cells   initially down-regulated CD62L at day 
7, but by day 63 only the OT-I T cells in the primary, but 
not secondary, memory group had substantial CD62L ex-
pression (Fig. 2 B). As   observed with endogenous responses, 
primary OT-I T cell responses exhibited progressive and 
relatively rapid reacquisition of CD62L with time after in-
fection, reaching >75% positive by day 63 (Fig. 2 C). 
CD62L expression by OT-I T cell populations undergoing a 
secondary response also appeared to increase with time but at 
a much slower rate than observed in the primary response 
(Fig. 2 C), with <20% of secondary memory OT-I T cells 
expressing CD62L at day 63. The disparity in CD62L ex-
pression between primary and secondary memory was also 
observed in blood, bone marrow, and lungs, and the traffi   ck-
ing of secondary memory CD8 T cells to lymph nodes was 
substantially impaired (unpublished data). Secondary mem-
ory CD8 T cells also exhibited a substantial delay in acquir-
ing the ability to produce IL-2 after in vitro antigen 
stimulation, another potentially important characteristic of 
TCM (11) (Fig. 2 D). Additional studies revealed that the 
CD62L expression and capacity to produce IL-2 by tertiary 
memory OT-I CD8 T cells were similarly, if not more, 
  delayed relative to secondary memory T cells (unpublished data). 
Figure 1.  Reduced CD62L expression of secondary compared with 
primary memory CD8 T cells in the same host. Approximately 2 × 104 
NP118-specifi  c CD8 T cells from a LCMV-immune BALB/c, Thy1.2 mouse 
(day 129 after infection) were adoptively transferred into naive, Thy1.1 
BALB/c mice. 1 d later, recipient mice were infected i.p. with LCMV-
Armstrong. At various time points after infection, the number of NP118-
specifi  c CD8 T cells undergoing either a primary or secondary response 
was assessed in the spleen by MHC tetramers (left) and differential Thy1 
expression (right). (A) Analysis of a representative mouse at day 8 after 
infection. Right panel gated on NP118/Ld tetramer+ cells. (B) Total number 
of NP118-specifi  c CD8 T cells in the spleen undergoing either a primary 
(■) or secondary (○) response over time. Data are mean ± SD for 
three mice/time point. (C) CD62L expression of NP118-specifi  c cells un-
dergoing either primary (top) or secondary (bottom) responses at day 8 
(left) or day 72 (right) after infection. Open histograms, CD62L; shaded 
histograms, isotype control. (D) Adoptive transfer recipients were infected 
with 107 actA− LM-NPs, and CD62L expression on primary (top) and 
secondary (bottom) NP118-specifi  c memory CD8+ T cells was determined 
39 d later. Shown are representative histograms of NP118/Ld tetramer gated 
cells. (E) Naive or LM-OVA–immune B6 mice were infected with 1.2 × 107 
actA− LM-OVA, and CD62L expression on primary (top) and secondary 
(bottom) ova257-specifi  c memory CD8+ T cells was determined 39 d later. 
Shown are representative histograms of ova257-specifi  c gated cells. 
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However, the data suggest that CD62L expression and the 
  capacity to produce IL-2 were slowly increasing in second-
ary memory CD8 T cells with time. Consistent with this 
notion,  50% of secondary memory OT-I T cells at day 227 
after infection expressed CD62L and 17% produced IL-2 in 
response to antigen (Fig. 2 E). Although this represents 
 60% of the level of expression of these molecules at day 
227 in the primary memory CD8 T cell population, the 
population of secondary memory OT-I T cells at day 227 
still had not   attained the CD62L expression or IL-2 produc-
tion capacity displayed by day 30 after infection in the primary 
OT-I T cell response. Together, these results demonstrate 
that secondary memory CD8 T cells acquire TCM charac-
teristics with a substantial delay compared with primary 
memory T cells.
It is possible that the precursors of the secondary memory 
CD8 T cells were derived solely from CD62Llo primary 
memory CD8 T cells (27). To address this possibility, we 
transferred purifi  ed  CD62Lhi cells from mice containing 
  primary memory or naive OT-I CD8 T cells (Fig. 3 A) into 
Figure 2.  OT-I CD8 T cells undergoing a secondary response do 
not adopt central–memory-like characteristics until very late 
time points after infection. 104-purified naive or primary memory 
(day 126 after infection) OT-I/Thy1.1 cells were adoptively transferred 
into separate groups of naive, Thy1.2 B6 mice, and recipient mice were 
subsequently infected with 1.4 × 107 actA− LM-OVA to initiate 
  primary and secondary responses, respectively. (A) Enumeration of 
OT-I cells (CD8+/Thy1.1+) in the spleen at days 7 and 63 after infec-
tion. Data are mean ± SD of three mice/group. (B) CD62L expression 
of OT-I cells in the spleen undergoing either primary (top) or second-
ary   responses (bottom) at days 7 (left) or 63 (right) after infection. 
Representative histograms are gated on CD8+/Thy1.1+ splenocytes. 
Open histograms, CD62L; shaded histograms, isotype control. 
(C) CD62L expression by OT-I cells undergoing either primary (■) or 
secondary (○) responses at various time points after infection. Data 
are mean ± SD of three mice/time point. (D) IL-2 production by pri-
mary and secondary memory OT-I cells detected by ova257-stimulated 
intracellular cytokine staining at various days after infection. Data are 
mean ± SD of three mice/time point. (E) Representative CD62L 
expression (left) and IL-2 production (middle and right) at 227 d after 
infection on primary (top) and secondary   (bottom) memory OT-I T cells. 
1°, primary; 2°, secondary.JEM VOL. 203, April 17, 2006  923
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  naive B6 mice. 1 d later, these mice were infected with   
LM-OVA, and we analyzed OT-I cells at days 7 and 44 after 
infection (Fig. 3 B). Similar to the previous results we ob-
tained with mixed TEM/TCM primary memory, we found that 
CD62Lhi primary memory CD8 T cells gave rise to second-
ary memory CD8 T cells that exhibited a delayed conversion 
to a CD62Lhi, TCM-like phenotype (Fig. 3 C). Therefore, 
the delayed acquisition of CD62L by secondary memory 
CD8 T cells is not a consequence of selective activation of 
TEM primary memory CD8 T cells.
Forced antigen-independent proliferation 
of secondary memory CD8 T cells effects adoption 
of a central–memory phenotype
One of the hallmarks of primary memory CD8 T cells, 
thought to be important in maintaining stable memory levels, 
is their ability to undergo proliferative renewal (basal prolif-
eration) in the absence of cognate antigen, or even MHC 
class I (29, 30). It has been suggested that primary TEM 
(CD62Llo) are able to convert directly to TCM (CD62Lhi) 
without proliferation (14); however, this fi  nding has recently 
been questioned (27). Thus, basal proliferation may facilitate, 
or even be required for, conversion of memory CD8 T cell 
populations from TEM to primarily TCM. To address this, we 
asked if secondary memory CD8 T cells undergo similar basal 
proliferation as primary memory CD8 T cells. BrdU treat-
ment to identify dividing cells was initiated at day 69 after the 
last LM-OVA infection, in mice containing either primary or 
secondary memory OT-1 T cells. A substantial fraction of 
primary memory OT-I T cells, both CD62Lhi and CD62Llo, 
incorporated BrdU during the 8-d pulsing period (Fig. 4 A). 
In striking contrast, few secondary memory OT-I T cells, 
whether CD62Lhi or CD62Llo, incorporated BrdU (Fig. 4 A), 
indicating that secondary memory CD8 T cells have a sub-
stantially reduced rate of basal proliferation compared with 
primary memory CD8 T cells. These data additionally indi-
cate that secondary memory CD8 T cells are not identical 
to primary TEM (CD62Llo), because primary TEM underwent 
basal proliferation.
Proliferative renewal of primary memory CD8 T cells 
  requires IL-15 (31–33), but not expression of the high-af-
fi  nity IL-15 receptor on the T cells themselves, where ex-
pression of CD122 and the common γ chain of the IL-2 
receptor are suffi   cient (34). To determine if modulation of 
the IL-15   response could account for the reduced basal 
proliferation of secondary memory cells, we compared 
CD122 expression and in vitro proliferation in response to 
IL-15 of purifi  ed   primary and secondary memory OT-I 
cells. Secondary memory CD8 T cells have reduced levels 
of CD122 on their   surface compared with primary mem-
ory CD8 T cells analyzed at the same time point after in-
fection (Fig. 4 B) and also display a reduced ability to 
proliferate in vitro in response to IL-15 (Fig. 4 C); the cell 
division in vitro supports the potential functional rele-
vance of the diff  erence in the levels of CD122 expression. 
Our preliminary evidence suggests that IL-15Rα expres-
sion is similar on both primary and secondary memory 
OT-I cells (unpublished data), suggesting that these results 
are not a consequence of diff  erential capacities to transpre-
sent IL-15 (35) in vitro. These data suggest that the re-
duced basal proliferation in secondary memory CD8 T cells 
could potentially result from decreased responsiveness of 
these cells to IL-15.
As mentioned previously, reduced basal proliferation 
could account for the delayed acquisition of TCM character-
istics in secondary memory CD8 T cells. As high dose IL-15 
induced proliferation of secondary memory CD8 T cells 
(Fig. 4 C), we asked whether secondary memory CD8 T 
cells that had undergone IL-15–mediated proliferation ex-
hibited an increased conversion to a central–memory phe-
notype. Purifi  ed secondary memory OT-I T cells cocultured 
in the presence of a high concentration of IL-15 divided, 
and successive generations of daughter cells exhibited in-
creased proportions of cells expressing high levels of CD62L 
(Fig. 4 E); in the absence of IL-15, the fraction of CD62Lhi 
secondary memory cells did not change from that observed 
directly ex vivo, before coculture (Fig. 4 D; unpublished 
data). Additionally, secondary memory CD8 T cells undergo 
Figure 3.  TCM primary memory CD8 T cells exhibit delayed CD62L 
reacquisition after infection. Primary memory OT-I CD8 T cells were 
generated in vivo as described in Fig. 2. (A) CD62Lhi cells were purifi  ed from 
splenocytes of mice containing primary memory OT-I cells as well as from 
naive OT-I mice. (B) Approximately 5 × 104 CD62Lhi-purifi  ed naive or pri-
mary memory CD8 T cells were then adoptively transferred into naive B6 
mice, and these mice were infected 1 d later with actA− LM-OVA. At days 
7 and 44 after infection, the numbers of OT-I cells were assessed. (C) At 
day 44 after infection, the CD62L expression of cells that had undergone a 
primary (top) or secondary (bottom) response was assessed. 1°, primary.924  COMPARING SECONDARY AND PRIMARY CD8 T CELL MEMORY | Jabbari and Harty
homeostatic proliferation in a sublethally irradiated host 
(Fig. 4 F), albeit at a reduced rate compared with primary 
memory CD8 T cells. These proliferating secondary mem-
ory CD8 T cells exhibited increased CD62L expression rel-
ative to cells transferred into a nonirradiated host, which did 
not divide (Fig. 4 G). These data highlight one potential mech-
anism to account for the slow conversion of secondary 
memory CD8 T cells to a central–memory phenotype: reduced 
Figure 4.  Reduced IL-15R expression and reduced responsiveness 
to IL-15 correlate with decreased basal proliferation and delayed 
central–memory phenotype. Primary and secondary memory OT-I CD8 
T cells were generated in vivo as described in Fig. 2. (A) Starting at day 69 
after infection, mice received BrdU for the following 8 d. Representative 
profi  les of primary and secondary memory OT-I cells for expression of 
surface CD62L and intracellular isotype control (IgG1, left two panels) or 
BrdU (right two panels). Contour plots are gated on CD8+Thy1.1+ cells. 
(B) Representative expression at 63 d after infection on primary memory 
OT-I cells of CD122 (open histogram), isotype control (vertical line-fi  ll), or 
secondary memory OT-I cells (CD122, shaded histogram), or isotype con-
trol (diagonal line-fi  ll). (C) Purifi  ed primary or secondary memory OT-I 
cells at 63 d after infection were labeled with CFSE and cocultured in 
the presence of 0, 50, or 200 ng/ml IL-15. After 3 d, dilution of CFSE as a 
measure of proliferation was assessed by fl  ow cytometry. Open histo-
grams, primary memory OT-I cells; shaded histograms, secondary memory 
OT-I cells. (D and E) Purifi  ed secondary memory OT-I cells at 75 d after 
infection were labeled with CFSE and cocultured for 3 d in the absence 
(D) or in the presence (E) of 200 ng/ml IL-15. Cells were subsequently 
stained for CD62L expression. Left-most panels, CFSE profi  le of cultured 
primary or secondary memory OT-I cells; right panels, CD62L profi  les of 
CFSE peaks as gated in top panels. (F and G) CFSE-labeled Thy1.1-purifi  ed 
primary or secondary memory OT-I cells were adoptively transferred into 
nonirradiated B6 mice or B6 mice sublethally irradiated 24 h prior. 14 d 
later, spleens of mice were harvested and assessed for CFSE dilution (F) or 
CD62L expression (G). 1°, primary; 2°, secondary.JEM VOL. 203, April 17, 2006  925
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basal proliferation, most likely as a result of reduced respon-
siveness to IL-15.
Secondary memory T cells potently expand and provide 
enhanced protection against L. monocytogenes
In some (14) but not all cases (36), primary TCM (CD62Lhi) 
are superior in mediating protective immunity to primary 
TEM (CD62Llo). Our studies suggested that secondary mem-
ory CD8 T cells exhibit reduced proliferative capacity in sev-
eral diff  erent circumstances relative to primary memory CD8 
T cells. To address whether secondary memory CD8 T cells 
have a reduced capacity to proliferate in response to infec-
tion, we transferred 5 × 105–purifi  ed primary or secondary 
memory Thy1.1 OT-I T cells (both at d 66 after LM-OVA 
infection) into naive B6 mice and determined the number of 
OT-I T cells in the spleen at days 0, 3, and 5 after LM-OVA 
challenge (Fig. 5 A). No substantial diff  erences in seeding of 
the spleen were observed in mice that received primary or 
secondary memory cells, and this approach generated a num-
ber of memory cells ( 5 × 104/spleen) in recipient mice 
that is less than that achieved in the endogenous response to 
LM-OVA (37). Importantly, we also observed no diff  erences 
in the antigen-driven proliferation of OT-I T cells between 
the groups of mice; in each case, expansion in the number 
of OT-I T cells was >1,000-fold by day 5 after challenge 
infection. These data indicate that, despite the reduced basal 
proliferation, secondary memory CD8 T cells are able to un-
dergo a vigorous proliferative response to infection.
Given their ability to potently expand in number in response 
to infection, we next compared the protective capacity of pri-
mary and secondary memory CD8 T cells against bacterial infec-
tion. Naive mice or mice that had received 5 × 106 primary or 
secondary memory OT-I T cells were challenged with a high 
dose of virulent LM-OVA, and the number of bacteria were 
determined at day 3 after challenge (Fig. 5 B). Mice containing 
primary memory OT-I T cells reduced the bacterial load  20-
fold in their spleens compared with mice without memory 
T cells, indicating protection by the primary memory CD8 T 
cells. Strikingly, mice that received the same number of second-
ary memory OT-I T cells had 500-fold fewer bacteria than the 
mice without memory T cells. These data suggest that, despite, 
or perhaps because of, their slow progression to a central–mem-
ory phenotype, secondary memory CD8 T cells are more potent 
in providing protective immunity than primary memory CD8 
T cells. This enhanced protection is most likely not mechanisti-
cally explained by an enhanced capacity to expand in response to 
infection. Additionally, the functional avidity of secondary mem-
ory OT-I cells, as measured by IFN-γ production in response to 
titrated amounts of peptide (38, 39), was no diff  erent than that of 
primary memory CD8 T cells (unpublished data), indicating that 
diff  erences in sensitivity to antigen also was not suffi   cient to ex-
plain the observed diff  erential protective capacities.
Enhanced lytic ability by secondary memory cells
A major eff   ector mechanism of memory CD8 T cells in 
  resistance to infection is cytolysis, whereby vectorial de-
granulation of preformed vesicles containing perforin and 
granzymes results in lysis of infected cells (5). Studies from 
our own lab demonstrate that perforin-dependent cytolysis is 
the major eff  ector mechanism of CD8 T cells in resistance to 
L. monocytogenes infection (39). To address the mechanism for 
enhanced protection by secondary memory CD8 T cells, we 
performed in vivo cytolytic assays. Our results indicate that 
secondary memory CD8 T cells have increased lytic capacity 
early after target cell transfer when compared with an equal 
number of primary memory CD8 T cells (Fig. 6, A and B). 
These results are consistent with the hypothesis that increased 
cytolytic potential accounts for the increased protective capac-
ity conferred by secondary memory CD8 T cells.
The in vivo lytic capacities were measured over the 
course of 2 h, consistent with the rapid perforin-granzyme–
mediated killing mechanism (40). We have already shown 
that this killing pathway is the predominant mechanism used 
to eradicate virulent L. monocytogenes (39). To address the 
mechanism(s) underlying the increased lytic capacity of sec-
ondary memory CD8 T cells, we examined the kinetics of 
degranulation (surface exposure of CD107a after in vitro 
peptide stimulation [41]) of primary and secondary memory 
CD8 T cells. We observed no diff  erence in the kinetic or 
Figure 5.  Robust expansion and enhanced protection in response 
to infection by secondary memory CD8 T cells. (A) 5 × 105 purifi  ed 
primary or secondary memory CD8 T cells (day 66 after infection) were 
adoptively transferred into separate groups of naive, Thy1.2 B6 mice. 1 d 
later, mice were infected with 1.5 × 107 actA− LM-OVA. Shown are total 
numbers of OT-I cells/spleen at days 0, 3, and 5 after infection of recipi-
ents of primary (■) or secondary (○) memory OT-I cells. Data represent 
mean ± SD from three mice/group/time point. (B) Approximately 5 × 105 
primary or secondary memory OT-I cells were adoptively transferred to 
naive, B6 recipients. 1 d later, mice were infected with 2.7 × 105 virulent 
LM-OVA. The number of bacteria in the spleen was determined 3 d after 
challenge infection. LOD, limit of detection. 1°, primary; 2°, secondary.926  COMPARING SECONDARY AND PRIMARY CD8 T CELL MEMORY | Jabbari and Harty
magnitude of degranulation between these populations (Fig. 
6, C and D), indicating that diff   erences in the rates of 
  degranulation are not suffi   cient to explain the observed in-
creased lytic capacities. Detectable intracellular granzyme 
B diff  erentiates highly lytic eff  ector CD8 T cells, from pri-
mary memory cells, either TEM or TCM, that generally express 
much reduced granzyme B and display decreased rapid 
ex vivo lytic function (41). Consistent with this explanation 
for enhanced killing by secondary memory CD8 T cells, we 
detected substantial granzyme B expression in secondary but 
not primary memory CD8 T cells (Fig. 6 E). These data 
demonstrate that secondary memory CD8 T cells remain 
more poised for rapid cytolysis relative to primary memory 
CD8 T cells, most likely caused by constitutive expression of 
the relevant lytic molecules. Additionally, secondary memory 
CD8 T cells are functionally distinct from TEM primary 
memory CD8 T cells, as CD62Llo-enriched (Fig. 7 A) sec-
ondary memory CD8 T cells provide enhanced protection 
Figure 6.  Secondary memory CD8 T cells exhibit enhanced in vivo 
killing capacity, equivalent degranulation kinetics, and increased 
expression of granzyme B compared with primary memory cells. 
(A) Approximately 1.5 × 106 primary (middle) or secondary memory 
(right) OT-I cells were adoptively transferred into naive B6 recipients. 
1 d later, recipient mice and a group of naive B6 mice (left) were injected 
with target cells consisting of 2 × 106 CFSEhi-labeled B6 splenocytes 
(no peptide) and 2 × 106 CFSElo-labeled B6 splenocytes (coated with 
ova257 peptide). Representative histograms of CFSE-labeled cells recovered 
from each group at 2 h after target cell injection. Number in histograms 
is percentage of specifi  c killing. (B) Cumulative data from three mice per 
group for the in vivo cytolysis assay. (C) Primary and secondary memory 
OT-I cells were assessed for degranulation (cell surface presence of 
CD107a) in the absence (left) or presence (right) of ova257 peptide at 
50 min after stimulation. Contour plots are gated on CD8+Thy1.1+ cells. 
(D) Percentage of primary (■) or secondary (○) memory OT-I T cells 
  expressing surface CD107a at various time points after peptide stimula-
tion. (E) Intracellular stain of primary (left) and secondary (right) mem-
ory OT-I cells obtained at 63 d after infection for granzyme B. Histograms 
are gated on CD8+Thy1.1+ cells. Open histograms, granzyme B; 
shaded histograms, isotype control. GrB, granzyme B. 1°,   primary; 
2°, secondary.JEM VOL. 203, April 17, 2006  927
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(Fig. 7, B and C), exhibit greater cytolytic capacity (Fig. 7, D 
and E), and express higher levels of granzyme B (Fig. 7 F) than 
their CD62Llo-enriched, TEM primary memory counterparts.
Secondary memory T cells allow priming of naive precursors
Relatively slow progression to TCM and the protracted con-
traction phase in secondary CD8 T cell response (6, 20, 21) 
may have evolved to maintain higher levels of protective im-
munity in areas with recurring pathogen exposure. In addi-
tion, the relatively slow acquisition of CD62L, and thus the 
reduced ability to enter lymph nodes could facilitate the 
priming of new naive CD8 T cells by eliminating the compe-
tition that would occur with CD62L-positive primary mem-
ory CD8 T cells (20, 42). In this way, multiple exposures to 
the same pathogen would result in priming of replacement 
memory T cells. To examine the traffi   cking of these popula-
tions, we used a novel homing assay, where CFSE-labeled 
primary memory Thy1.1 OT-I T cells were mixed with un-
labeled primary or secondary memory Thy1.1 OT-I T cells 
to achieve a known input population (Fig. 8 A). These mixed 
populations were then injected into naive B6 (Thy1.2) mice, 
where the ratio of labeled to unlabeled OT-I T cells recov-
ered in various tissues serves as a normalized homing index to 
primary memory OT-I T cells. We found that the ratios of 
labeled to unlabeled primary memory OT-I T cells recovered 
from various tissues did not change from the input ratios (Fig. 
8, B and C), demonstrating that the CFSE labeling proce-
dure had no adverse eff  ect on the traffi   cking of cells to tissues. 
Figure 7.  CD62Llo secondary memory CD8 T cells offer greater 
protection and exhibit more effi  cient cytolysis than CD62Llo, pri-
mary TEM. Primary and secondary memory OT-I/Thy1.1 CD8 T cells were 
generated in vivo as described in Fig. 2. Splenocytes were harvested and 
depleted of CD62Lhi-expressing cells. (A) CD62L expression on OT-I cells 
pre and after purifi  cation. (B) Approximately 9.2 × 105 CD62Llo primary or 
secondary memory OT-I/Thy1.1 CD8 T cells were adoptively transferred 
into naive, Thy1.2-expressing B6 mice. 1 d later, spleens of recipient mice 
were harvested and stained for CD8 and Thy1.1. (C) 1 d after transfer, 
recipient mice were infected with 1.27 × 106 virulent LM-OVA. 3 d after 
infection, the bacterial burden in the spleens of three to fi  ve infected mice 
per group was assessed as in Fig. 6. Two out of fi  ve naive mice died. One 
out of three recipients of secondary memory OT-I cells did not have 
detectable levels of LM-OVA. Line, limit of detection. (D) Recipients of 
CD62Llo primary or secondary memory CD8 T cells were injected with 
target cells consisting of 1.25 × 106 CFSEhi-labeled B6 splenocytes 
(no peptide) and 1.25 × 106 CFSElo-labeled B6 splenocytes (coated with 
ova257 peptide). Representative histograms of CFSE-labeled cells recov-
ered from each group at 2 h after target cell injection. Number in histo-
grams is percentage of specifi  c killing. (E) Cumulative data from three 
mice per group for the in vivo cytolysis assay. (F and G) Unpurifi  ed pri-
mary (F) and secondary (G) memory OT-I cells were harvested from 
spleens and stained for CD62L and intracellular granzyme B directly 
ex vivo. Left panels are gated on OT-I cells, middle panels are gated on 
CD62Llo OT-I cells, and right panels are gated on CD62Lhi OT-I cells. 
1°, primary; 2°, secondary.928  COMPARING SECONDARY AND PRIMARY CD8 T CELL MEMORY | Jabbari and Harty
In contrast, we observed modest increases in the homing of 
secondary memory cells to the spleen and blood with a more 
noticeable increase in homing to the lung (Fig. 8, B and D). 
However, we saw a substantial decrease in homing of second-
ary memory cells to the lymph nodes, consistent with the re-
duced expression of CD62L in the population.
The inability of secondary memory CD8 T cells to home 
to lymph nodes has the potential to eliminate competition for 
priming of naive T cell responses that has been observed with 
primary memory CD8 T cells (20, 42). Alternatively, en-
hanced protection by secondary memory CD8 T cells could 
result in faster clearance of infection and a reduction of new 
Figure 8.  Decreased capacity of secondary memory CD8 T cells 
to traffi  c to lymph nodes permits enhanced priming of naive CD8 
T cells. (A) Primary memory OT-I cells generated in Thy1.2 B6 mice were 
labeled with CFSE and mixed with unlabeled primary (top) or secondary 
(bottom) memory OT-I cells (Thy1.1+). Histograms of the CFSE profi  les are 
gated on CD8+Thy1.1+ cells. Approximately 3 × 106 memory OT-I cells in 
these mixed populations were adoptively transferred into naive Thy1.2 B6 
mice. (B) Representative histograms obtained 3 d after transfer of blood, 
spleens, bone marrow (BM), lymph nodes, and lungs were assessed for 
presence of unlabeled primary (top) or secondary (bottom) memory OT-I 
cells relative to CFSE-labeled primary memory OT-I cells. Representative 
histograms, gated on CD8+Thy1.1+ cells, are shown. (C) Percentage 
of unlabeled primary and (D) secondary memory OT-I cells (mean ± SD of 
three mice/group) in various tissues compared with input. (E) Primary and 
secondary memory OT-I T cells were generated in Thy1.2 B6 mice. At day 
69 after infection, naive mice (top) or with preexisting primary (middle) or 
secondary (bottom) OT-I memory received 106 naive, CFSE-labeled OT-I 
cells. 1 d later, mice were injected with  1.2 × 107 actA− LM-OVA s.c. in 
the lower right fl  ank. Proliferation of the CFSE-labeled naive OT-I cells 
was assessed in inguinal lymph nodes contralateral (left) and ipsilateral 
(right) to the injection site at 2 d after infection. Representative histo-
grams, gated on CD8+Thy1.1+CFSE+OT-I cells, are shown. Numbers are 
the percentages of CFSE-labeled cells that had undergone cell division. 
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T cell responses. To diff  erentiate between these possibilities, 
we generated primary and secondary OT-I memory mice 
and, 69 d after infection, transferred 106 CFSE-labeled, puri-
fi  ed naive OT-I T cells into each group, as well as into naive 
mice. 1 d later, all groups were challenged by subcutaneous 
LM-OVA infection at a single site on the right fl  ank. Priming 
of the naive OT-I T cells, as indicated by CFSE dilution, was 
assessed in the draining ipsilateral as well as contralateral in-
guinal lymph nodes at day 2 after infection (Fig. 8 E). LM-
OVA infection resulted in substantial proliferation of the 
CFSE-labeled naive OT-I T cells in mice that did not contain 
memory OT-I T cells. As previously described (20, 42), the 
predominantly CD62Lhi primary memory OT-I T cell popu-
lation effi   ciently competed for priming with the naive OT-I 
T cells, substantially reducing the fraction of OT-I T cells that 
had diluted CFSE. In contrast, despite their enhanced ability 
to control LM infection, secondary memory OT-I T cells 
only minimally inhibited the response from naive OT-I 
T cells. These data suggest that the relatively slow acquisition 
of CD62L by secondary memory CD8 T cells may occur, in 
part, to facilitate replacement of secondary memory CD8 
T cells with newly primed memory CD8 T cells while main-
taining an environment of enhanced protective immunity.
DISCUSSION
Acute infections have the potential to generate high levels of 
protective CD8 T cell memory that can persist for the life of 
the organism (1, 8). Although an extensive body of literature 
describing CD8 T cell memory has been amassed, the vast ma-
jority of these studies have focused on primary memory cells 
that arise after a single infection or vaccination. Importantly, in 
the case of vaccination, a single immunization may not be suffi   -
cient to generate an adequate level of immunity for protection 
from infection, and a temporally separated booster immuni-
zation may be required (2). The characteristics of secondary 
responses, specifi  cally the extent to which secondary CD8 
T memory diff  ers from primary CD8 T memory is, therefore, 
critical for the optimization of vaccination protocols.
Here we have shown, in infection models that diff  er with 
respect to mouse strain, pathogen, antigen, and host environ-
ment, that secondary CD8 T cell responses result in memory 
populations that have unique qualities that distinguish them 
from primary memory CD8 T cell populations. As defi  ned 
by CD62L expression and IL-2 production, primary CD8 
T cell responses after acute infection pass relatively rapidly 
through an eff  ector–memory phase and stabilize as a predom-
inantly TCM population. In contrast, secondary memory CD8 
T cells appear to be severely delayed in this progression. Fur-
thermore, secondary memory CD8 T cells, besides sharing a 
similarly low CD62L expression level, are clearly not the 
same as primary TEM; secondary memory CD8 T cells display 
reduced basal proliferation, a higher level of expression of 
cytolytic molecules, exhibit more potent cytolytic capabili-
ties, and are more protective than primary TEM.
The IL-15–driven basal proliferation important for the 
long-term maintenance of primary memory CD8 T cells is 
substantially reduced in secondary memory CD8 T cells, 
which may account for the delayed acquisition of TCM char-
acteristics. This correlation between the rate of cell division 
and the acquisition of a central–memory phenotype for 
memory CD8 T cells may be explained by several possibili-
ties. One possibility is that cell division is a necessary step be-
fore memory cells can reexpress CD62L. However, studies 
by others (14) do not support this hypothesis. Another possi-
bility that may explain the correlation between cell division 
and CD62L acquisition is that TCM may accumulate faster 
than TEM, resulting in an increase in the representation of 
TEM over time. Proponents of this hypothesis often cite data 
that indicate that TCM undergo a faster rate of basal prolifera-
tion than TEM (14). However, it is necessary that the death 
rate of this population is also known to invoke preferential 
accumulation; it is possible for a dividing population to de-
crease in total numbers if its death rate is greater than that 
which can be replenished by cell division. Resolution of this 
issue will likely require progress in understanding the death 
rate of memory T cell populations.
We found that secondary memory CD8 T cells are not 
only equally able to undergo expansion in response to anti-
gen, but are better at immediate cytolysis and protecting hosts 
against challenge by a virulent pathogen compared with pri-
mary memory CD8 T cells of the same specifi  city. Addition-
ally, their decreased representation in the lymph nodes and 
therefore increased representation in the peripheral organs 
may be a mechanism to maintain highly lytic memory CD8 
T cells for longer periods at potential sites of pathogen entry. 
In this way, the host may tailor memory CD8 T cell migra-
tion to circumstances in which infection with the same 
pathogens are a recurring event.
Immediately after an infection, the preexisting naive CD8 
T cell population becomes activated by receiving antigenic 
and costimulatory signals in the secondary lymphoid organs 
and will eventually diff  erentiate into a memory CD8 T cell 
population (43, 44). Throughout these responses, new naive 
CD8 T cells of the same specifi  city will be populating the 
periphery, either through thymic or extrathymic develop-
ment (45). Also, it may be possible that, during an initial in-
fection, not all of the preexisting naive CD8 T cells will have 
been recruited to respond (46). Therefore, it is likely that 
most anamnestic CD8 T cell responses include both primary 
and secondary responses (20). Here, we show that traffi   cking 
into lymph nodes by secondary memory CD8 T cells is se-
verely decreased compared with primary memory CD8 
T cells, which more rapidly adopt a CD62Lhi central–memory 
phenotype. Because primary memory CD8 T cells are pres-
ent in lymph nodes, they are able to suppress a new naive 
CD8 T cell response from occurring by, most simply, com-
peting for presented antigen on dendritic cells (42). Because 
secondary memory CD8 T cells, on the other hand, are 
  excluded from entering the lymph nodes until very late time 
points after infection, they are more permissive for the initia-
tion of a new naive CD8 T cell response. Their exclusion 
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the generation of a higher number of replacement memory 
cells in future exposures to the same pathogen.
In terms of immune function, is there a compelling rea-
son to keep secondary memory CD8 T cells out of lymph 
nodes for extended periods? Secondary memory CD8 T cells 
are, by defi  nition, the progeny of many rounds of division 
caused by the expansion phase of their initial response, their 
maintenance by basal proliferation as primary memory CD8 
T cells, and the expansion phase of their secondary response. 
Although telomerase is thought to be activated in responding 
CD8 T cells (47, 48), potentially permitting many more divi-
sions before senescence compared with other cells, even 
memory T cells will likely reach a limit of division. Thus, 
delayed acquisition of CD62L by secondary memory CD8 
T cells may be a mechanism to allow for a new population of 
CD8 T cell memory to be generated from naive precursors 
while maintaining adequate or even enhanced protection 
from infection. These results have practical implications for 
vaccines that rely on multiple immunizations by defi  ning an 
optimal window for the third boost, before the reacquisition 
of CD62L. This may result in both effi   cient boosting of sec-
ondary memory CD8 T cells as well as the most eff  ective 
generation of new primary CD8 T cell responses. This ap-
proach to timing may ensure that the induced memory is 
long lasting and able to respond to multiple encounters with 
the specifi  c pathogen.
In cases where the induction of humoral responses by vac-
cination is not suffi   cient to protect against pathogenic infec-
tion, the generation of CD8 T cell memory has substantial 
potential in the rational design of vaccines (49). Insuffi   cient 
primary memory CD8 T cell responses may be boosted 
by secondary immunizations, which quantitatively enhance 
memory cell numbers and alter certain qualitative aspects of 
memory. Whether secondary memory CD8 T cells will be 
more protective, as shown in our studies with L. monocytogenes 
against all, or only a subset, of pathogens, is a critical issue for 
the design of the most potent vaccines. For example, a potent 
CD8 T cell response to a single immunization may be most 
eff  ective against one subset of pathogens, whereas a low prim-
ing vaccination and robust booster immunization to generate 
secondary CD8 T cell memory may be more eff  ective against 
another subset of pathogens. Comparison of primary and sec-
ondary memory CD8 T cells for protection against a variety 
of pathogens will be required to resolve this issue.
MATERIALS AND METHODS
Mice, L. monocytogenes, and LCMV. C57BL/6 (B6) and BALB/c mice 
were obtained from the National Cancer Institute, Frederick, MD. Thy1.1 
BALB/c mice were provided by Dr. Richard Dutton (Trudeau Institute, 
Saranac Lake, NY). OT-I TCR-tg mice have been previously described (28). 
L. monocytogenes expressing the ovalbumin gene (LM-OVA) was obtained 
from Dr. Hao Shen (University of Pennsylvania, Philadelphia, PA) and 
Dr. Leo Lefrancois, (University of Connecticut, Farmington, CT). Mice were 
bred and maintained in our animal facilities at the University of Iowa. All an-
imal protocols were approved by the University of Iowa Institutional Animal 
Care and Use Committee. Attenuated strains of LM (actA− LM-OVA [26] 
and actA− XFL303 [50]) were previously described. For infections, LM were 
grown and injected i.v. as described (51). The number of colony-forming 
units was confi  rmed by plating dilutions on selective media. LCMV-
Armstrong (2 × 105 plaque-forming units) was injected i.p. as described (52).
Antibodies and reantigenents. Antibodies of the indicated specifi  cities 
and with the appropriate combination of conjugated fl  uorophores were used 
in these studies: IFN-γ, Thy1.1, BrdU, CD107a, CD62L, IL-2, IgG2a, 
IgG1, CD8 (BD PharMingen), IgG2b, CD122, Thy1.2 (eBiosciences), and 
granzyme B (CalTantigen). Granzyme B stain of splenocytes was performed 
after treatment with Brefeldin A (BD PharMingen). CFSE (Molecular 
Probes) was used at 0.5 μM, unless indicated otherwise, to label cells. BrdU 
(BD PharMingen) was injected i.p. (2 mg) on the fi  rst day and was adminis-
tered in the drinking water (0.8 mg/ml) for 8 d. Synthetic peptides NP118-126 
(NP118) and ova257-264 (ova257) have been previously described (24, 28).
Intracellular cytokine staining. Intracellular cytokine staining was per-
formed as previously described (53). In brief, splenocytes were cocultured 
with Brefeldin A in the presence or absence of specifi  c peptide for 6 h. Cells 
were then washed, surface stained, and treated with Cytofi  x/Cytoperm (BD 
PharMingen) before staining for cytokines.
Generation of primary and secondary responses in the same mouse. 
We generated primary and secondary responses in the same mouse as previ-
ously described (20). In brief, splenocytes from a LCMV-immune BALB/c 
Thy1.2 mouse, containing  1.5–2 × 104 NP118-specifi  c CD8 T cells, 
were adoptively transferred i.v. into naive, Thy1.1 BALB/c mice. These 
mice were then infected i.p. with LCMV-Armstrong, and the subsequent 
responses were distinguished by diff  erential Thy1 expression.
Generation of primary and secondary memory OT-I cells. OT-I/
Thy1.1 splenocytes were CD8 enriched by negative selection (Milltenyi 
Biotech), and 2 × 104 cells were adoptively transferred into naive, Thy1.2 
B6 mice. Recipient mice were infected i.v. with  1 × 107 actA− LM-OVA. 
Over 100 d later, spleens were harvested and OT-I cells purifi  ed using anti–
Thy1.1-PE and anti-PE magnetic beads. Approximately 5 × 104 purifi  ed 
primary memory OT-I cells were adoptively transferred into a new group 
of naive Thy1.2 B6 mice. At the same time, an equal number of Thy1.1-
purifi  ed naive OT-I cells were adoptively transferred into a group of naive 
Thy1.2 B6 mice. Both groups of mice were infected with 107 actA− LM-
OVA to generate secondary and primary OT-I responses. For primary and 
secondary memory OT-I studies, spleens were harvested around 65 d after 
infection, and memory OT-I cells were purifi  ed by anti–Thy1.1-PE anti-
bodies and anti-PE magnetic beads. For experiments that dealt with purify-
ing or depleting CD62Lhi cells, spleens containing primary or secondary 
memory OT-I cells were harvested and stained with anti–CD62L-PE and 
anti-PE magnetic beads before AutoMACS purifi  cation.
In vitro culture with IL-15. Purifi  ed OT-I memory T cell populations 
were CFSE labeled, and 105 of either cell type was cultured in vitro in a 
96-well round bottom plate in the presence of 0, 50, or 200 ng/ml IL-15 
(Peprotech). CFSE dilution was assessed by fl  ow cytometry 3 d later.
Homeostatic proliferation in irradiated hosts. 105 CFSE-labeled, 
Thy1.1-purifi  ed primary or secondary memory OT-I cells were adoptively 
transferred into hosts irradiated (6.5 Gys) 24 h earlier. At the same time, 5 × 105 
cells were transferred into nonirradiated B6 hosts. After 14 d, spleens were 
harvested and CFSE dilution was assessed by fl  ow cytometry.
Degranulation assay. Splenocytes were cultured with monensin (BD 
PharMingen) and anti–CD107a-FITC in the presence or absence of 1 μM 
specifi  c peptide. At diff  erent time points after infection, cells were washed 
and surface stained for the indicated markers.
In vivo cytolytic assay. The indicated number of primary and secondary 
memory OT-I cells were adoptively transferred into naive, Thy1.2 B6 mice. 
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CFSE and 2 × 106 splenocytes pulsed with 1 μM specifi  c peptide and la-
beled with 0.0625 μM CFSE was administered i.v. to the indicated groups 
as well as a control group that received no memory cells. 2 h later, spleens 
were harvested, and the percentages of CFSE+ cells that were CFSEhi and 
CFSElo was assessed fl  ow cytometrically. The percent killing was calculated 
as: 100 – (100 × [(% CFSElo/% CFSEhi)/(% CFSElo in no memory cells 
group/% CFSEhi in no memory cells group)]).
In vivo protection. The indicated number of primary and secondary 
memory OT-I T cells were adoptively transferred into naive, Thy1.2 B6 
mice. Mice were subsequently challenged with the indicated dose of virulent 
LM-OVA, and bacterial numbers were determined in spleen homogenates 
3 d later as described (17).
Lymphocyte isolation. Other than blood, the organs and tissues were har-
vested after cardiac perfusion with PBS and heparin. Axillary and inguinal 
lymph nodes were pooled and mechanically disrupted using frosted glass 
slides. Bone marrow was aspirated from femurs and tibias. Spleens and lungs 
were forced through metal meshes. Where appropriate, RBCs were lysed 
with ACK buff  er.
Ability to prime new naive response. Primary and secondary memory 
Thy1.2 OT-I T cells were generated as described earlier. Approximately 
65 d after infection, CD8-enriched, CFSE-labeled naive OT-I/Thy1.1 cells 
were adoptively transferred into these mice. The following day, mice were 
injected s.c. with  1 × 107 actA− LM-OVA in the right lower fl  ank. 2 d af-
ter infection, ipsilateral and contralateral inguinal lymph nodes were har-
vested, and CFSE dilution was monitored in CD8+Thy1.1–positive cells by 
fl  ow cytometry. Contralateral lymph nodes were pooled before analysis.
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